A computer-assisted management program for antibiotics and other antiinfective agents

被引:763
作者
Evans, RS
Pestotnik, SL
Classen, DC
Clemmer, TP
Weaver, LK
Orme, JF
Lloyd, JF
Burke, JP
机构
[1] Latter Day St Hosp, Dept Clin Epidemiol, Salt Lake City, UT 84143 USA
[2] Latter Day St Hosp, Dept Crit Care, Salt Lake City, UT 84143 USA
[3] Latter Day St Hosp, Dept Med Informat, Salt Lake City, UT 84143 USA
关键词
D O I
10.1056/NEJM199801223380406
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background and Methods Optimal decisions about the use of antibiotics and other antiinfective agents in critically ill patients require access to a large amount of complex information. We have developed a computerized decision-support program linked to computer-based patient records that can assist physicians in the use of antiinfective agents and improve the quality of care. This program presents epidemiologic information, along with detailed recommendations and warnings. The program recommends antiinfective regimens and courses of therapy for particular patients and provides immediate feedback. We prospectively studied the use of the computerized antiinfectives-management program for one year in a 12-bed intensive care unit. Results During the intervention period, all 545 patients admitted were cared for with the aid of the antiinfectives-management program. Measures of processes and outcomes were compared with those for the 1136 patients admitted to the same unit during the two years before the intervention period. The use of the program led to significant reductions in orders for drugs to which the patients had reported allergies (35, vs. 146 during the preintervention period; P<0.01), excess drug dosages (87 vs. 405, P<0.01), and antibiotic-susceptibility mismatches (12 vs. 206, P<0.01). There were also marked reductions in the mean number of days of excessive drug dosage (2.7 vs. 5.9, P<0.002) and in adverse events caused by antiinfective agents (4 vs. 28, P<0.02). In analyses of patients who received antiinfective agents, those treated during the intervention period who always received the regimens recommended by the computer program (n=203) had significant reductions, as compared with those who did not always receive the recommended regimens (n=195) and those in the preintervention cohort (n=766), in the cost of an tiinfective agents (adjusted mean, $102 vs. $427 and $340, respectively; P<0.001), in total hospital costs (adjusted mean, $26,315 vs. $44,865 and $35,283; P<0.001), and in the length of the hospital stay (adjusted mean, 10.0 vs. 16.7 and 12.9 days; P<0.001). Conclusions A computerized antiinfectives-management program can improve the quality of patient care and reduce costs. (C) 1998, Massachusetts Medical Society.
引用
收藏
页码:232 / 238
页数:7
相关论文
共 28 条
[1]   Quality and the medical marketplace - Following elephants [J].
Angell, M ;
Kassirer, JP .
NEW ENGLAND JOURNAL OF MEDICINE, 1996, 335 (12) :883-885
[2]   Payment by capitation and the quality of care .5. [J].
Berwick, DM .
NEW ENGLAND JOURNAL OF MEDICINE, 1996, 335 (16) :1227-1231
[3]   Quality of care .1. What is it? [J].
Blumenthal, D .
NEW ENGLAND JOURNAL OF MEDICINE, 1996, 335 (12) :891-894
[4]   DOSE-RESPONSE EFFECT OF ADJUVANT CHEMOTHERAPY IN BREAST-CANCER [J].
BONADONNA, G ;
VALAGUSSA, P .
NEW ENGLAND JOURNAL OF MEDICINE, 1981, 304 (01) :10-15
[5]   Breaking the chain of antibiotic resistance [J].
Burke, JP ;
Pestotnik, SL .
CURRENT OPINION IN INFECTIOUS DISEASES, 1996, 9 (04) :253-255
[6]   Improving the quality of care .3. [J].
Chassin, MR .
NEW ENGLAND JOURNAL OF MEDICINE, 1996, 335 (14) :1060-1063
[7]   THE TIMING OF PROPHYLACTIC ADMINISTRATION OF ANTIBIOTICS AND THE RISK OF SURGICAL-WOUND INFECTION [J].
CLASSEN, DC ;
EVANS, RS ;
PESTOTNIK, SL ;
HORN, SD ;
MENLOVE, RL ;
BURKE, JP .
NEW ENGLAND JOURNAL OF MEDICINE, 1992, 326 (05) :281-286
[8]   COMPUTERIZED SURVEILLANCE OF ADVERSE DRUG EVENTS IN HOSPITAL PATIENTS [J].
CLASSEN, DC ;
PESTOTNIK, SL ;
EVANS, RS ;
BURKE, JP .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1991, 266 (20) :2847-2851
[9]  
CLASSEN DC, 1992, JAMA-J AM MED ASSOC, V267, P1922
[10]   Adverse drug events in hospitalized patients - Excess length of stay, extra costs, and attributable mortality [J].
Classen, DC ;
Pestotnik, SL ;
Evans, RS ;
Lloyd, JF ;
Burke, JP .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1997, 277 (04) :301-306